Open Access

[Corrigendum] Long non‑coding RNA CASC11 interacts with YBX1 to promote prostate cancer progression by suppressing the p53 pathway

  • Authors:
    • Xianchao Sun
    • Shiyong Xin
    • Ying Zhang
    • Liang Jin
    • Xiang Liu
    • Jiaxin Zhang
    • Wangli Mei
    • Bihui Zhang
    • Weiguo Ma
    • Lin Ye
  • View Affiliations

  • Published online on: November 27, 2023     https://doi.org/10.3892/ijo.2023.5593
  • Article Number: 5
  • Copyright : © Sun et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

View Figures

Related Articles

Journal Cover

January-2024
Volume 64 Issue 1

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Sun X, Xin S, Zhang Y, Jin L, Liu X, Zhang J, Mei W, Zhang B, Ma W, Ye L, Ye L, et al: [Corrigendum] Long non‑coding RNA CASC11 interacts with YBX1 to promote prostate cancer progression by suppressing the p53 pathway. Int J Oncol 64: 5, 2024
APA
Sun, X., Xin, S., Zhang, Y., Jin, L., Liu, X., Zhang, J. ... Ye, L. (2024). [Corrigendum] Long non‑coding RNA CASC11 interacts with YBX1 to promote prostate cancer progression by suppressing the p53 pathway. International Journal of Oncology, 64, 5. https://doi.org/10.3892/ijo.2023.5593
MLA
Sun, X., Xin, S., Zhang, Y., Jin, L., Liu, X., Zhang, J., Mei, W., Zhang, B., Ma, W., Ye, L."[Corrigendum] Long non‑coding RNA CASC11 interacts with YBX1 to promote prostate cancer progression by suppressing the p53 pathway". International Journal of Oncology 64.1 (2024): 5.
Chicago
Sun, X., Xin, S., Zhang, Y., Jin, L., Liu, X., Zhang, J., Mei, W., Zhang, B., Ma, W., Ye, L."[Corrigendum] Long non‑coding RNA CASC11 interacts with YBX1 to promote prostate cancer progression by suppressing the p53 pathway". International Journal of Oncology 64, no. 1 (2024): 5. https://doi.org/10.3892/ijo.2023.5593